Traders sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading hours on Thursday. $92.14 million flowed into the stock on the tick-up and $122.96 million flowed out of the stock on the tick-down, for a money net flow of $30.82 million out of the stock. Of all equities tracked, Johnson & Johnson had the 0th highest net out-flow for the day. Johnson & Johnson traded up $1.52 for the day and closed at $132.19

A number of equities research analysts have recently issued reports on the company. UBS AG reaffirmed a “buy” rating and set a $136.00 target price on shares of Johnson & Johnson in a research report on Monday, May 15th. Vetr raised Johnson & Johnson from a “hold” rating to a “buy” rating and set a $132.33 target price on the stock in a research report on Thursday, May 18th. J P Morgan Chase & Co boosted their target price on Johnson & Johnson from $140.00 to $148.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 16th. Stifel Nicolaus reaffirmed a “hold” rating and set a $128.00 target price (up from $124.00) on shares of Johnson & Johnson in a research report on Thursday, May 18th. Finally, BidaskClub raised Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 17th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and ten have given a buy rating to the stock. Johnson & Johnson has an average rating of “Hold” and a consensus price target of $134.60.

The stock has a market cap of $351.55 billion, a PE ratio of 22.16 and a beta of 0.79. The company’s 50-day moving average price is $132.48 and its 200 day moving average price is $128.74.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Tuesday, July 18th. The company reported $1.83 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.79 by $0.04. Johnson & Johnson had a return on equity of 26.76% and a net margin of 22.52%. The firm had revenue of $18.84 billion for the quarter, compared to the consensus estimate of $18.94 billion. During the same quarter last year, the business posted $1.74 EPS. The company’s revenue for the quarter was up 1.9% on a year-over-year basis. Analysts forecast that Johnson & Johnson will post $7.18 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Tuesday, August 29th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 2.57%. The ex-dividend date is Friday, August 25th. Johnson & Johnson’s dividend payout ratio is 56.76%.

In other Johnson & Johnson news, VP Paulus Stoffels sold 102,692 shares of Johnson & Johnson stock in a transaction dated Monday, July 24th. The stock was sold at an average price of $133.14, for a total value of $13,672,412.88. Following the sale, the vice president now owns 230,342 shares of the company’s stock, valued at approximately $30,667,733.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Dominic J. Caruso sold 82,591 shares of Johnson & Johnson stock in a transaction dated Thursday, July 20th. The shares were sold at an average price of $136.72, for a total value of $11,291,841.52. Following the completion of the sale, the vice president now directly owns 226,693 shares in the company, valued at approximately $30,993,466.96. The disclosure for this sale can be found here. Company insiders own 0.19% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Harding Loevner LP acquired a new stake in shares of Johnson & Johnson in the second quarter valued at about $106,000. Lenox Wealth Advisors Inc. increased its position in shares of Johnson & Johnson by 0.7% in the first quarter. Lenox Wealth Advisors Inc. now owns 871 shares of the company’s stock valued at $108,000 after acquiring an additional 6 shares during the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its position in shares of Johnson & Johnson by 29.9% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after acquiring an additional 200 shares during the last quarter. IHT Wealth Management LLC increased its position in shares of Johnson & Johnson by 46.4% in the second quarter. IHT Wealth Management LLC now owns 10,942 shares of the company’s stock valued at $122,000 after acquiring an additional 3,467 shares during the last quarter. Finally, Mountain Capital Investment Advisors Inc acquired a new stake in shares of Johnson & Johnson in the second quarter valued at about $124,000. 66.00% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Traders Sell Johnson & Johnson (JNJ) on Strength (JNJ)” was first published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/09/09/traders-sell-johnson-johnson-jnj-on-strength-jnj-2.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.